News
News
Pharma Pulse
Academy
Publications
Partner Perspectives
More
Webcasts
Resources
Conferences
Conference Coverage
Conference Listing
Events
Videos
Videos
Peer Exchange
Podcasts
Editorial Podcasts
Sponsored Podcasts
Subscribe
My Account
News
Academy
Publications
Partner Perspectives
Webcasts
Resources
Conferences
Events
Videos
Podcasts
Subscribe
Brand & Product Security
Legal & Regulatory
Trade & Brand Protection
Traceability
Business and Finance
Cold Chain
Containers & Shippers
Software
Devices
Commercial Channels
Data & Technology
Real World Data
Digitalization
Artificial Intelligence
Logistics & Transportation
Manufacturing & Packaging
3PL
Supply Chain
Market Access
Pricing
Commercialization
Trade & Channel
Opinion
Patient Support
Patient Assistance Programs
HUB Services
Adherence
Choose Topic
Spotlight -
Digital Editions
|
Security
|
Asembia AXS25 Summit
Advertisement
Brand Insights - Thought Leadership / Paid Program | Movilitas
The DSCSA dilemma: How to legitimately sell returned medicine
By
October 15th 2020
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
FTC–Express Scripts Settlement Targets PBM Rebates, Transparency, and Patient Drug Costs
2
How AI Orchestration Is Reinventing Healthcare Supply Chain Resilience
3
TrumpRx Launches With MFN-Based Drug Discounts
4
Pharma's Year of Two Halves
5
The Great Repricing: Commercial Channel Under Pressure
